Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure

被引:26
作者
Gardner, Roy S. [1 ]
Chong, Kwok S. [1 ]
O'Meara, Eileen [2 ]
Jardine, Alan [3 ]
Ford, Ian [4 ]
McDonagh, Theresa A. [5 ]
机构
[1] Royal Infirm, Dept Cardiol, Glasgow G31 2ER, Lanark, Scotland
[2] Montreal Heart Inst, Quebec City, PQ, Canada
[3] Western Infirm & Associated Hosp, Dept Nephrol, Glasgow, Lanark, Scotland
[4] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland
[5] Royal Brompton Hosp, Dept Cardiol, London, England
关键词
natriuretic peptides; renal dysfunction; prognosis; heart failure;
D O I
10.1093/eurheartj/ehm480
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims This study evaluates the prognostic utility of renal dysfunction estimated by the recently validated modi. cation of diet in renal disease (MDRD) equations and compares it with the currently most promising predictor of prognosis in patients with advanced heart failure. Methods and results We prospectively studied 182 consecutive patients with advanced chronic heart failure (CHF) referred for consideration of cardiac transplantation, with a median follow-up of 642 days. Glomerular filtration rate (GFR) was estimated using the MDRD equations and plasma taken for NT-proBNP analysis. The primary endpoint of all-cause mortality was reached in 40 patients (13.2% crude 1-year mortality), and the combined secondary endpoint of all-cause mortality or urgent CTx was reached in 44 patients. The mean GFR estimated by MDRD-1 was 58 mL/min/1.73 m(2). The median NT-proBNP concentration was 1505 ( 517-4014) pg/mL. Although GFR estimated by MDRD-1 was a univariate marker of all-cause mortality, the only predictor of either endpoint independent of other variables was an NT-proBNP concentration above the median. Conclusion NT-proBNP appears superior to GFR estimated by MDRD in patients with advanced CHF. Moreover, NT-proBNP was able to identify patients with a poor prognosis whose GFR was already low.
引用
收藏
页码:3027 / 3033
页数:7
相关论文
共 27 条
  • [1] Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation
    Aaronson, KD
    Schwartz, JS
    Chen, TM
    Wong, KL
    Goin, JE
    Mancini, DM
    [J]. CIRCULATION, 1997, 95 (12) : 2660 - 2667
  • [2] Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction
    Al-Ahmad, A
    Rand, WM
    Manjunath, G
    Konstam, MA
    Salem, DN
    Levey, AS
    Sarnak, MJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) : 955 - 962
  • [3] Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
  • [4] B-type natriuretic peptide predicts sudden death in patients with chronic heart failure
    Berger, R
    Huelsman, M
    Strecker, K
    Bojic, A
    Moser, P
    Stanek, B
    Pacher, R
    [J]. CIRCULATION, 2002, 105 (20) : 2392 - 2397
  • [5] CLELAND JGF, 1987, BRIT HEART J, V58, P572
  • [6] The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction
    Dries, DL
    Exner, DV
    Domanski, MJ
    Greenberg, B
    Stevenson, LW
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) : 681 - 689
  • [7] FLEMING JS, 2004, BRIT NUCL MED SOC CL
  • [8] N-terminal brain natriuretic peptide, but not anemia, is a powerful predictor of mortality in advanced heart failure
    Gardner, RS
    Chong, KS
    Morton, JJ
    Mcdonagh, TA
    [J]. JOURNAL OF CARDIAC FAILURE, 2005, 11 (05) : S47 - S53
  • [9] The prognostic use of right heart catheterization data in patients with advanced heart failure: How relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones?
    Gardner, RS
    Henderson, G
    McDonagh, TA
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (03) : 303 - 309
  • [10] N-terminal brain natriuretic peptide is a more powerful predictor of mortality than endothelin-1, adrenomedullin and turnour necrosis factor-α in patients referred for consideration of cardiac transplantation
    Gardner, RS
    Chong, V
    Morton, L
    McDonagh, TA
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (02) : 253 - 260